These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 60145)

  • 1. Mesangial cell dysfunction detected by accumulation of aggregated protein in rats with streptozotocin induced diabetes.
    Wardle EN
    Biomedicine; 1975 Oct; 23(8):299-302. PubMed ID: 60145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kidney in streptozotocin diabetic rats. Morphologic, ultrastructural, and function studies.
    Weil R; Nozawa M; Koss M; Weber C; Reemtsma K; McIntosh R
    Arch Pathol Lab Med; 1976 Jan; 100(1):37-49. PubMed ID: 130091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular basement membrane: biosynthesis and chemical composition in the streptozotocin diabetic rat.
    Beisswenger PJ
    J Clin Invest; 1976 Oct; 58(4):844-52. PubMed ID: 135002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesangial uptake and processing of macromolecules in rats with diabetes mellitus.
    Mauer SM; Steffes MW; Chern M; Brown DM
    Lab Invest; 1979 Nov; 41(5):401-6. PubMed ID: 502472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regression of diabetic glomerular changes following islet transplantation. A study of rats with streptozotocin diabetes].
    Kösters W
    Fortschr Med; 1979 May; 97(17):825-9. PubMed ID: 155638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats.
    Leehey DJ; Singh AK; Bast JP; Sethupathi P; Singh R
    Transl Res; 2008 Apr; 151(4):208-16. PubMed ID: 18355768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose synthesis from labelled precursors in kidney cortical slices of normal, diabetic, cortisone-treated and growth hormone-treated rats.
    Joseph PK; Subrahmanyam K
    Indian J Biochem; 1970 Mar; 7(1):45-9. PubMed ID: 4248093
    [No Abstract]   [Full Text] [Related]  

  • 10. Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels.
    Geoffroy K; Troncy L; Wiernsperger N; Lagarde M; El Bawab S
    FEBS Lett; 2005 Feb; 579(5):1249-54. PubMed ID: 15710421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies.
    Xu ZG; Ryu DR; Yoo TH; Jung DS; Kim JJ; Kim HJ; Choi HY; Kim JS; Adler SG; Natarajan R; Han DS; Kang SW
    Nephrol Dial Transplant; 2005 Mar; 20(3):524-31. PubMed ID: 15647309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of glomerular SREBP-1c in diabetic nephropathy.
    Ishigaki N; Yamamoto T; Shimizu Y; Kobayashi K; Yatoh S; Sone H; Takahashi A; Suzuki H; Yamagata K; Yamada N; Shimano H
    Biochem Biophys Res Commun; 2007 Dec; 364(3):502-8. PubMed ID: 17961514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
    Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
    J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
    Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
    Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of beta1 integrins in glomerular tissue of Streptozotocin-induced diabetic rats.
    Regoli M; Bendayan M
    Biochem Cell Biol; 1999; 77(1):71-8. PubMed ID: 10426288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal microvascular changes in streptozotocin-induced, long-termed diabetic rat.
    Sricharoenvej S; Tongpob Y; Lanlua P; Piyawinijwong S; Roongruangchai J; Phoungpetchara I
    J Med Assoc Thai; 2007 Dec; 90(12):2677-82. PubMed ID: 18386720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment.
    Ceol M; Nerlich A; Baggio B; Anglani F; Sauer U; Schleicher E; Gambaro G
    Lab Invest; 1996 Feb; 74(2):484-95. PubMed ID: 8780166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of nicotinamide against nephropathy in diabetic rats.
    Wahlberg G; Carlson LA; Wasserman J; Ljungqvist A
    Diabetes Res; 1985 Nov; 2(6):307-12. PubMed ID: 2934204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Increased synthesis of glomerular basement membrane collagen in streptozotocin diabetes.
    Grant ME; Harwood R; Willams IF
    J Physiol; 1976 May; 257(1):56P-57P. PubMed ID: 133240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.